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Food allergic hypersensitive responses are mediated 
through immunoglobulin E (IgE)1 in allergic individuals. 
Soybean and peanut can cause human allergic reactions 
and rank among the eight most significant food allergens 
[1, 2]. They both belong to the legume family and share 
high similarity in many of their seed storage proteins [3]. 
In vitro IgE cross-reactions between soybean and peanut 
are not uncommon. Serum samples from patients aller-
gic to soybean or peanut proteins often contain IgE that 
can react with seed proteins from either species [4–8]. The 
occurrence of peanut allergy is more frequent in west-
ern countries and the responses are frequently severe. Al-
lergic reactions to peanut are often life-long and occur in 
both children and adults. Conversely, soybean allergic re-
actions can be transient, occurring more often in children 
and normally do not cause severe allergic responses [3]. It 
had been shown that the cross-reactions between soybean 
and peanut proteins might not be clinically significant [6–
9]. However, a recent study indicated that soybean pro-
teins might be underestimated as a cause of severe aller-
gic response in the general population of peanut-allergic 
patients [10]. This finding, as well as increased reports of 
soybean allergy linked to the greater use of soybean pro-
tein in the food industry [2], raises new concerns for soy-
bean allergy and its impact on people with known or la-
tent allergies to peanut [10]. It is evident that we need 
careful biochemical and immunological studies to eval-
uate IgE-binding proteins in both species, with a goal 
of identifying homologous epitopes that can potentially 
elicit serious allergic reactions [3]. 
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Abstract
To identify conserved immunoglobulin E (IgE)-binding epitopes among legume glycinins, we utilized recombinant 
soybean G2a and G2a-derived polypeptide fragments. All of these fusion polypeptides bound IgE, and the C-termi-
nal 94-residue fragment appeared to bind more IgE. Using synthetic peptides we identified S219–N233 (S219GFAPE-
FLKEAFGVN233) as the dominant IgE-binding epitope. Alanine scanning of this epitope indicated that six amino ac-
ids (E224, F225, L226, F230, G231, and V232) contributed most to IgE binding. Among these amino acids, only G231 
of soybean G2a is not conserved in soybean G1a (S234) and peanut Ara h 3 (Q256). Synthetic peptides corresponding 
to the equivalent regions in G1a and Ara h 3 bound IgE in the order Ara h 3 ≥ soybean G2a > soybean G1a. This se-
quence represents a new IgE-binding epitope that occurs in a highly conserved region present in legume glycinins. 
Such IgE-binding sites could provide a molecular explanation for the IgE cross-reactivity observed between soybean 
and peanut proteins. 
Keywords: Soybean allergens, Peanut, Recombinant proteins, IgE cross-reactivity, Epitope mapping, Conserved epit-
ope, Alanine scanning 
Abbreviations: IgE, immunoglobulin E; G1a, glycinin G1 acidic chain; G2a, glycinin G2 acidic chain; SDS, sodium do-
decyl sulfate; PCR, polymerase chain reaction; TBST, Tris-buffered saline-Tween 20; HRP, horseradish peroxidase.
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Our studies have focused on the soybean glyci-
nins because of their abundance (>20% of seed dry 
weight) in soybean seeds and their high sequence sim-
ilarity with other legume family storage proteins. Na-
tive glycinins are hexamers of 350 kDa, and each sub-
unit is composed of a 40-kDa acidic and a 20-kDa basic 
chain that are linked through interchain disulfides [11, 
12]. Both chains of soybean glycinin proteins bind IgE 
from soybean allergic patients [13, 14]. Soybean glyci-
nins have high sequence similarity with peanut Ara h 
3 [15, 16]. Epitope mapping for IgE-binding has been 
performed for glycinin G1 acidic chain (G1a), glycinin 
G2 acidic chain (G2a), and Ara h 3 in previous stud-
ies, and there were some sequence similarities in some 
of these identified epitopes [16–18]. However, in these 
studies sera from patients with known peanut allergies 
were used in the epitope mapping of Ara h 3 and sera 
from patients with known soybean allergies were used 
to identify G1a or G2a epitopes. In our current study, 
we have focused on finding conserved IgE-binding ep-
itopes among these three related glycinins. The same 
serum, containing IgE interacting with both soybean 
and peanut, was used for discovering a conserved IgE-
binding epitope in the glycinins. 
Materials and methods 
Construction, expression, and purification of recombinant 
fusion proteins of glycinin G1a and G2a. Recombinant G1a 
and G2a were generated and purified as thioredoxin-fu-
sion proteins using the pBAD/TOPO expression system 
following manufacturer-supplied protocols (Invitrogen) 
as described previously [17]. 
Construction of recombinant proteins of glycinin G2a frag-
ments. Two recombinant proteins representing the N-
terminal, G2af1, and the C-terminal, G2af2, fragments 
of G2a were constructed. The PCR primers designed for 
the G2af1 were G2aBADL (50-gcccata tgagaga gcaggc) 
and G2a208RHindIII (5′-aagcttttg ttgctttcct ttc); the PCR 
primers designed for G2af2 were G2a203LNdeI (5′-catat-
gcagaaaggaaagcaac) and G2a296RHindIII (5′-aagcttttt-
gctttggcg). All primers were synthesized by Sigma–
Genosys (The Woodlands, TX). PCR reactions were 
performed for 30 cycles using Taq polymerase (Gibco-
BRL). PCR products were purified from 1% agarose gel 
and ligated into the PCR2.1–TOPO vector using the TA 
system (Invitrogen). The ligated DNA was transformed 
into Escherichia coli Top10 cells following manufacturer 
recommended protocols (Invitrogen). Constructs con-
taining inserts with the predicted sizes were sequenced 
in the Genomics Core Research Facility of the University 
of Nebraska–Lincoln. Sequence-verified inserts were 
subsequently obtained by double digestions using NdeI 
and HindIII restriction endonucleases and ligated into 
the pET28a vector (Novagen). 
Expression and purification of recombinant proteins. 
The pET28a plasmids containing sequence-verified in-
serts were transformed into E. coli BL21 (DE3) cells. E. 
coli containing either the G2af1 or the G2af2 construct 
were grown in 5 ml LB medium containing kanamycin 
(50 μg/ml) at 37 °C overnight and used to inoculate 250 
ml LB medium containing kanamycin (50 lg/ml). Cul-
tures were grown at 37 °C with shaking at 200× rpm un-
til the A600 reached approximately 0.5. At that time, cells 
were induced with 0.5 mM isopropyl β-d-thiogalacto-
pyranoside. Cells were grown for an additional 3 h at 
37 °C and harvested by centrifugation at 5000g for 5min 
at 4 °C. Purification of the recombinant proteins was as 
described by Beardslee et al. [17]. Fusion protein pu-
rity was evaluated by SDS– PAGE as described below. 
Protein concentrations were analyzed by the BCA assay 
(Pierce). Purified proteins were stored in aliquots at –20 
°C until used. 
Electrophoretic separation. Aliquots of recombinant 
proteins (2 lg for G1a or G2a, 1 μg for G2af1 or G2af2) 
were mixed with an equal volume of SDS–PAGE sam-
ple loading buffer (100 mM Tris–HCl, pH 6.8, 4% SDS, 
0.2% bromophenol blue, 20% glycerol, and 200 mM di-
thiothreitol) and heated to 95 °C for 5 min. After cool-
ing, samples were analyzed on 12.5% SDS–PAGE gels 
[19]. Proteins were stained with 0.1% Coomassie bril-
liant blue R-250. 
Human serum used for study. Soybean-allergic serum 
from an adult female approximately 45 years old was 
purchased from Plasma-Lab (Everett, WA). This pa-
tient had positive skin prick tests to both soybean and 
peanut. She had a reported history of allergic reactions 
to many beans and experienced anaphylaxis with pea-
nut. The IgE level of this serum was 192 IU/ml, soy-
bean-specific IgE was 4.0 IU/ml, and peanut-specific 
IgE was 37.5 IU/ml. One patient with high IgE level 
(1285 IU/ml) but no reported soybean- or peanut-al-
lergic reactions was used as a negative control. 
Immunoblotting. For immunoblotting after SDS– PAGE 
separation, proteins were transferred to PVDF mem-
branes (Millipore, Immobilon-P) in a tank apparatus 
overnight at 10 V in transfer buffer (10 mM Tris–HCl, 
100 mM glycine, 10% methanol) at 4 °C. Membranes 
were blocked overnight with TBST (25 mM Tris–Cl, pH 
7.5, 150 mM NaCl, 0.05% Tween 20), containing 5% non-
fat dry milk, and subsequently incubated overnight at 
4 °C with human serum diluted 1:20 in blocking buffer. 
After extensive washes (3 × 30 min) with TBST, mem-
branes were incubated with horseradish peroxidase 
conjugated to goat anti-human IgE (Bethyl Labs, Mont-
gomery, TX) diluted 1:10, 000 in TBST. Membranes were 
washed as above with TBST and antigen–antibody com-
plexes were detected by chemiluminescence using the 
ECL plus reagent (Amersham Pharmacia, Piscataway, 
NJ) and imaged using Biomax ML film (Kodak). Films 
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were developed using an automatic developer (Kodak 
M35A, X-OMAT Processor). 
Peptide synthesis on SPOT membrane. Individual pep-
tides were synthesized on a modified SPOT cellulose 
membrane (Sigma–Genosys) containing free hydroxyl 
groups using Fmoc amino acids according to Frank [20] 
and manufacturer-supplied protocols (Sigma–Geno-
sys). After the addition of the last amino acid, the cel-
lulose membranes were treated with trifluoroacetic 
acid/dichloromethane/triisopropylsilane (1:1:0.5) to de-
block side-chain protecting groups. The membrane was 
washed sequentially with dichloromethane, dimethyl 
formamide, and methanol; dried; and stored at –20 °C 
until needed or used directly for the IgE-binding assay 
as described below. 
IgE-binding assay of SPOT membrane. The SPOT mem-
brane containing the synthetic peptides was washed 
with TBS and blocked overnight at 4 °C with blocking 
buffer, TBST containing 5% sucrose and 1 × membrane 
blocking buffer (Sigma–Genosys). The membrane was 
incubated overnight at 4 °C with the appropriate hu-
man serum diluted 1:2 in blocking buffer, washed in 
TBST, and incubated with goat anti-human IgE–horse-
radish peroxidase (Bethyl Labs) diluted 1:5000 in block-
ing buffer and developed using chemiluminescence as 
described above. 
Structural analysis of G2a IgE epitope. The amino acid 
sequence for glycinin G2 (SwissPort Accesssion, P04405) 
was submitted for modeling to SWISS-MODEL [21] us-
ing the soybean glycinin G1 crystal structure [22] as a 
template. To view the trimeric structure, the glycinin G1 
structure was used. The sequence alignment generated 
by SWISS-MODEL was used to highlight residues corre-
sponding to the G2a IgE epitope. The Swiss-PdbViewer 
program was used for model manipulation and 3D ren-
dering was performed with POV-Ray 3. 
Results 
Expression, purification, and IgE-binding ability of recom-
binant soybean G1a and G2a proteins. Recombinant G1a 
and G2a proteins were constructed as thioredoxin fu-
sions and were purified by nickel-affinity chromatogra-
phy (Figure 1A). The G2a fusion protein apparently dis-
played IgE binding greater than that of the G1a fusion 
protein (Figure 1B). 
C-terminal fragment of G2a binds IgE more strongly than 
N-terminal fragment. To identify potential epitopes on 
G2a, we produced two recombinant proteins represent-
ing the N-terminal and C-terminal portions of G2a. The 
G2af1 coded for R20-Q208, the N-terminal 189 amino ac-
ids of mature G2a after cleavage of the signal peptide of 
the first 19 residues. The G2af2 fragment coded for Q203-
K296, the C-terminal 94 amino acids of G2a. Both G2a 
fragments also contained a 6histidine purification tag 
and were purified using a nickel-affinity column (Figure 
2A). When equal amounts of purified recombinant pro-
teins of G2af1 and G2af2 (1 μg each) were loaded on the 
SDS–PAGE and transferred to the PVDF membrane, the 
G2af2 fragment exhibited stronger IgE-binding ability to 
the serum sample used in this study (Figure 2B). From 
the calculated intensities of the immunoblots (areas ob-
tained from scans) the IgE binding of G2af2 was esti-
mated to be about four times more than that of G2af1. 
Based on the approximately twofold difference in the 
molar amounts loaded on the gels, the G2af2 fragment 
displayed an apparent twofold greater affinity for IgE 
binding as compared to the N-terminal G2af1 fragment. 
Serum from a soybean-tolerant individual and second-
ary antibody controls did not exhibit IgE binding to the 
G2a fragments (data not shown). These results indicated 
that the majority of IgE-binding was to the C-terminal 
fragment of G2a. 
Figure 1. IgE binding to recombinant G1a protein and G2a 
protein. (A) Purified recombinant G1a protein (Lane 1, 2 μg) 
and G2a protein (Lane 2, 2 μg) were separated by 12.5% SDS–
PAGE and stained with Coomassie blue. (B) Immunoblotting 
of recombinant G1a protein (Lane 1, 2 μg) and G2a protein 
(Lane 2, 2 μg) with serum. After SDS– PAGE separation, pro-
teins were transferred to PVDF and immunoblotting was per-
formed as described under Materials and methods. Antibody 
dilutions were 1:20 for soybean-sensitive sera and 1:10, 000 for 
goat anti-human IgE–HRP. 
Figure 2. IgE-binding ability of purified recombinant G2a 
fragments: G2af1 and G2af2. (A) Equal amount of purified 
recombinant G2af1 protein (Lane 1, 1 μg) and G2af2 protein 
(Lane 2, 1 μg) were separated by a 12.5% SDS–PAGE and 
stained with Coomassie blue. (B) Immunoblotting of recom-
binant G2af1 protein (Lane 1, 1 μg) and G2af2 protein (Lane 
2, 1 μg) with serum. After 12.5% SDS–PAGE separation, pro-
teins were transferred to PVDF and immunoblotting was per-
formed as described under Materials and methods. Antibody 
dilutions were 1:20 for soybean–sensitive sera and 1:10, 000 for 
goat antihuman IgE-HRP. 
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Epitopes in the G2af2 fragment. We next set out to iden-
tify the IgE-binding epitope within the G2af2 fragment. 
Twelve overlapping 15-mer peptides with eight amino 
acid overlaps corresponding to the G2af2 sequence were 
synthesized on modified cellulose paper and probed 
with the soybean-sensitive serum (Figure 3). Only pep-
tide 3, corresponding to the region S219–N233 of G2a, 
exhibited strong IgE binding (Figure 3). After longer 
exposure time, peptide 7, corresponding to E247–V261 
of G2a, also showed some IgE binding. IgE binding to 
these peptides was not detected with control serum 
(data not shown). To identify the amino acids critical 
for IgE binding in peptide 3, a series of related peptides 
were synthesized on a SPOT membrane with alanine 
substitutions at each position of the 15-mer epitope and 
their IgE-binding abilities were evaluated (Figure 4). A 
significant loss of IgE binding was observed after ala-
nine was substituted for F225 (spot 9), L226 (spot 8), and 
F230 (spot 4). Substitution of G231 (spot 3), V232 (spot 
2), and E224 (spot 10) with alanine also resulted in low-
ered IgE binding. Substitution of alanine at other posi-
tions on this peptide did not cause a consistent decrease 
in IgE binding. Furthermore, a concerted change of the 
first three (S219–F221) (spot 15) or first five (S219–P223) 
(spot 16) amino acids to alanine did not substantially de-
crease IgE binding (Figure 4). Thus the central IgE-bind-
ing region of this peptide is between E224 and V232. The 
most critical amino acids for IgE binding were identified 
 
 
 
 
 
 
 
 
 
 
 
 
as F225, L226, and F230. Other amino acids that contrib-
uted to IgE binding were G231, E224, and V232. 
Comparison of the epitope in soybean G2a with cor-
responding peptides in soybean G1a and peanut Ara h 
3. The new epitope on G2a identified here shares high 
sequence identity to the corresponding regions of soy-
bean G1a and peanut Ara h 3. Out of the 15 amino ac-
ids in G2a, 6 and 5 are different in soybean G1a and pea-
nut Ara h 3, respectively (Figure 5). Synthetic peptides 
based on the sequence of G1a and Ara h 3 correspond-
ing to the equivalent region of the G2a epitope exhib-
ited IgE binding (Figure 5). Based on the IgE-binding as-
say, the order of the IgE-binding ability to the synthetic 
peptides in the G2a epitope region was Ara h 3 (spot 
6) ≥ G2a (spot 1) > G1a (spot 5) (Figure 5). Among the 
six amino acids shown to be crucial for IgE binding in 
Figure 3. Epitope mapping of G2af2. Twelve 15-mer peptides 
representing the whole G2af2 region were manually synthe-
sized on a SPOT membrane as described under Materials and 
methods. Adjacent peptides had an eight amino acid overlap. 
The membrane was probed with the soybean sensitive sera 
(1:2 dilution) and bound IgE was detected by goat anti-human 
IgE–HRP (1:5000 dilution). The antigen–antibody complexes 
were detected by chemiluminescence. Peptide 3, which exhib-
ited IgE binding and corresponded to the region of residues 
S219– N233 of G2a protein, is underlined. The amino acid se-
quence of this peptide is shown in bold. 
Figure 4. Alanine scanning of residues important for IgE 
binding in peptide 3 shown in Figure 3. Fourteen peptides 
represented as spots 1–14 were manually synthesized on a 
SPOT membrane. Peptide 5 represented the wild-type se-
quence. Peptides 15 and 16 were synthesized with the first 
three or five amino acids substituted with alanine residues. 
Alanine substitutions are underlined and shown in bold. The 
membrane was probed with the soybean-sensitive sera (1:2 di-
lution) and bound IgE was detected with goat anti-human IgE–
HRP (1:5000 dilution). The antigen–antibody complexes were 
detected by chemiluminescence. 
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G2a (see Figure 4), E224, F225, L226, F230, and V232 in 
G2a are conserved in G1a and Ara h 3. However, G231 
in G2a corresponds to S234 in G1a and Q256 in Ara h 3 
(Figure 5). Thus, we synthesized the G2a epitope pep-
tide on a SPOT membrane with single amino acid sub-
stitutions, namely, G231 to serine or G231 to glutamine. 
The G231 to A231 mutant of the G2a epitope was used 
as a control. The strength of IgE binding to these pep-
tides was Q231 (spot 3) ≥ G231 (spot 1) > S231 (spot 2) ≈ 
A231 (spot 4) (Figure 5). A peptide representing the cor-
responding region from peanut Ara h 1, which has 10 
different amino acids as compared to the G2a epitope, 
did not show IgE binding (Figure 5). 
Structural analysis of the identified G2a IgE epit-
ope. The crystal structure for soybean glycinin G1 [22] 
was used to analyze the location of the G2a IgE epitope 
identified in this study. The tertiary structure of glycinin 
subunits is composed of a central jelly-roll β-barrel with 
α helical protrusions on either side [22]. The G2a IgE ep-
itope encompasses an α helix at the subunit interface 
that is represented in red (Figure 6A). A surface map of 
the glycinin trimer reveals that this IgE epitope is acces-
sible in the trimeric state (Figure 6B). Additionally, since 
trimers stack upon one another with their large surface 
area as the interface [22], this IgE epitope would also be 
accessible in the hexameric state. 
Discussion 
In this study, we have focused on investigating con-
served IgE epitopes of three well-documented allergenic 
glycinins, namely, soybean G1a and G2a and peanut 
Ara h 3. In previous studies, pooled sera from soy-
bean-sensitive patients has been used to determine ep-
Figure 5. Comparison of the new epitope from G2a with the 
peptides corresponding in sequence from soybean G1a and 
peanut Ara h 3. Seven 15-mer peptides were manually synthe-
sized on a SPOT membrane as spots 1–7. Spot 1 was the wild-
type G2a epitope. Spots 2–4 were mutants, in which G231 of 
the G2a epitope was substituted with serine (peptide 2), glu-
tamine (peptide 3), or alanine (peptide 4). Spots 5 and 6 corre-
spond to the pertinent regions from soybean G1a and peanut 
Ara h 3, respectively. Spot 7 represented the corresponding re-
gion from peanut Ara h 1. The membrane was probed with 
the soybean-sensitive sera (1:2 dilution) and any bound IgE 
was detected using goat anti-human IgE–HRP (1:5000 di-
lution). The antigen–antibody complexes were detected by 
chemiluminescence. 
Figure 6. Structural location of the G2a IgE epitope. (A) The 
soybean glycinin G1 crystal structure [23] was used to model 
the location of the G2a IgE epitope. A ribbon diagram shows 
the individual subunits of the glycinin trimer represented in 
different colors. The G2a IgE epitope is represented in red for 
all three subunits. (B) A surface map of the glycinin trimer was 
generated with Swiss-PdbViewer and colored as in panel A. 
The trimer is rotated to show the surface-accessible area of the 
G2a IgE epitope. 
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itopes of soybean G1a [17] and soybean G2 (including 
both acidic and basic chains) [18]. In comparing the ep-
itope sequences reported in these studies, except for a 
seven amino acid overlap for one epitope, none of the 
other identified epitopes displayed significant sequence 
identity [17, 18]. This was somewhat surprising be-
cause soybean G1a and G2a proteins share significant 
amino acid identity in their acidic chains. However, the 
identification of different epitopes in these studies may 
be attributed to serum differences. 
Our initial data revealed that the acidic chains of 
both soybean G1 and G2 recombinant proteins bind IgE 
(Figure 1B). We postulated that common epitopes can 
exist in these legume seed storage proteins and started 
our search with the stronger IgE-binding soybean pro-
tein, G2a. Using recombinant protein fragments of G2a, 
we established the dominant epitope region as residing 
on the C-terminal end of the G2a protein (Figure 2B). 
Subsequently the linear epitope was identified as the 
sequence S219–N233 (SGFAPEFLKEAFGVN) near the 
C-terminus of G2a (Figure 3). Another peptide E247– 
V261 showed weak IgE binding and was not examined 
further. Interestingly, this weak epitope has been pre-
viously identified in G2a [18], as well as in the corre-
sponding sequences of G1a [17] and Ara h 3 [16]. Al-
anine scanning mutagenesis of the dominant linear 
epitope of G2a revealed that six amino acids (E224, 
F225, L226, F230, G231, V232) contributed most toward 
its IgE binding (Figure 4). The absence of the F230, 
G231, and V232 in peptide 2 and E224 and F225 in pep-
tide 4 in Figure 3 may explain the lack of IgE binding 
to these peptides. 
The dominant G2a epitope identified in this study is 
new as it was not among the five previously reported 
IgE-binding epitopes identified by Helm et al. [18] for 
soybean G2a. Interestingly, this G2a epitope was part 
of a corresponding region of a G1a epitope identified 
by our group in an earlier study [17] and was also ad-
jacent to an Ara h 3 epitope (G240–A254) identified by 
Rabjohn et al. [16]. Structurally, this potentially aller-
genic epitope is located in a domain between two vari-
able regions of legume glycinins, which have been 
identified as residing on the surface of the protein and 
susceptible to protease cleavage [12, 23]. In the ter-
tiary structure of the glycinin trimer, this domain cor-
responds to the subunit interface region (Figure 6A). 
While the α helix encompassed by the G2a IgE epitope 
is not entirely surface accessible in the trimeric state 
(Figs. 6A and B), dissociation of the subunits would re-
veal the α helix as a protrusion that would be attractive 
for antibody binding. This portion of the glycinin mol-
ecule may represent a particularly allergenic domain of 
legume seed storage proteins, since several IgE-binding 
epitopes have been identified within this linear stretch 
of the glycinin and homologous vicilin sequences [16–
18, 24, 25]. 
To test the hypothesis that this region represents an 
allergenic region of glycinins in general, we synthesized 
peptides based on the G2a epitope (Figure 5) that repre-
sented the corresponding region of G1a and Ara h 3. All 
of these synthetic peptides demonstrated IgE binding 
even though their apparent binding strengths were dif-
ferent. The synthetic peptide corresponding to the G1a 
sequence had less IgE-binding ability than the G2a ep-
itope while the synthetic peptide corresponding to the 
Ara h 3 sequence displayed the strongest IgE binding 
among the three peptides. These results are consistent 
with the general observation that peanut seed proteins 
are more potent allergens than soybean proteins [3]. 
Out of the six amino acids in the G2a epitope important 
for IgE binding (Figure 4), only one amino acid, G231, 
was different in G1a (S234) or Ara h 3 (Q256). Interest-
ingly, by substituting one crucial amino acid (G231/S or 
G231/Q) of the G2a epitope for the corresponding resi-
due present in G1a or Ara h 3, we could mimic the IgE-
binding ability observed for synthetic peptides that rep-
resented the sequences of these three glycinins (Figure 
5). These results suggest that cross-reactivity for soy-
bean- or peanut-allergenic individuals is a potential 
problem, especially since glycinins are the most abun-
dant seed storage proteins. In summary, our current 
study has identified a common IgE-binding epitope site 
present in three related legume glycinin proteins: soy-
bean G1a and G2a and peanut Ara h 3. This site could 
contribute to the cross-reactions observed in sera from 
peanut- and soybean-sensitive individuals. 
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